Nadia Waheed - 01 Jun 2024 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Signature
/s/ Donald Notman, Attorney-in-Fact for Nadia Waheed
Issuer symbol
OCUL
Transactions as of
01 Jun 2024
Net transactions value
$0
Form type
4
Filing time
04 Jun 2024, 17:28:11 UTC
Next filing
13 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Award $0 +141,666 $0.000000 141,666 01 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +425,000 $0.000000 425,000 01 Jun 2024 Common Stock 425,000 $5.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 1, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on the date of grant.
F2 Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter.